Texas cancer fund seeks fresh start
Critics question whether institute has resolved conflicts between commercial and scientific goals.
Corrected:
"It must be hard filling a position when the last person in the job was a Nobel laureate who quit in protest over a disregard for peer review, and whose departure triggered an avalanche of other resignations.
.............................
Controversy erupted in May after Gilman, who won the 1994 medicine Nobel, tendered his resignation in a strongly worded letter criticizing a $20-million commercial ‘incubator’ grant that had been awarded without scientific review. Much of the grant was slated for a group led by Lynda Chin at the University of Texas MD Anderson Cancer Center in Houston, where Chin’s husband, Ronald DePinho, is president. CPRIT internal correspondence that was subsequently made public through freedom-of-information rules suggests that the grant criteria were tailored to improve Chin’s eligibility (see Nature 486, 169–170; 2012). At the same time as the incubator grant was awarded, a set of grants recommended for approval by the CPRIT’s scientific council stalled."
No comments:
Post a Comment